Luminex Virtual Patent Marking
The following Luminex products are protected by patents in the United States and elsewhere. This web page is provided to satisfy the virtual patent marking provisions of various jurisdictions including the virtual patent marking provisions of Section 16 of the America Invents Act. The following list of products and patents may not be all inclusive. For example, some products listed here may be covered by patents in the United States and elsewhere that are not listed, and other products not listed here may be protected by one or more patents in the United States and elsewhere. The products may be sold individually or as a part of a combination product, kit, or system, and the listed patents would apply in both cases. Additional patents may be pending in the United States or elsewhere.
Luminex, MAGPIX, FLEXMAP 3D, ARIES, VERIGENE, Flex, xPONENT, MicroPlex, LumAvidin, xTAG, MultiCode, xMAP, NxTAG, Muse, Guava, Guava Nexin, Amnis, ImageStream, FlowSight, CellStream, Ideas, SpeedBead, and FlowCellect are trademarks of Luminex Corporation, registered in the U.S. and other countries. SeroMAP, Luminex 100, Luminex 200, MagPlex-TAG, easyCyte, InCyte, Inspire, easyCheck, ViaCount, xMAP INTELLIFLEX, and GuavaSoft are trademarks of Luminex Corporation. MultiFLEX is a trademark of GenArraytion, Inc.
Instruments and Software
MAGPIX®
This product, or use thereof, is covered in whole or in part by US Patent Nos. 8,031,918, 8,296,088, 8,274,656, 8,532,351, 8,542,897, 8,798,951, 8,859,996, 8,889,347, 9,063,088, 9,286,504, 9,292,938, 9,767,344, 10,108,844, 10,846,508, and 11,125,678; Australian Patent Nos. 2010253487, 2011280055, and 2014250695; European (UK) Patent Nos. EP1929274, EP2769198, and EP2261635; Hong Kong Patent Nos. HK1166128, HK1173828, and HK1200209; and foreign counterparts thereof.
Luminex® 100™
This product, or use thereof, is covered in whole or in part by US Patent Nos. 7,318,336, and 7,523,637; Australian Patent No. 2010202161; European (UK) Patent No. EP1754965; Hong Kong Patent No. HK1148587; and foreign counterparts thereof.
Luminex® 200™
This product, or use thereof, is covered in whole or in part by US Patent Nos. 7,318,336, and 7,523,637; Australian Patent No. 2010202161; European (UK) Patent No. EP1754965; Hong Kong Patent No. HK1148587; and foreign counterparts thereof.
FLEXMAP 3D®
This product, or use thereof, is covered in whole or in part by US Patent Nos. 7,318,336, and 7,523,637; Australian Patent Nos. 2010202161 and 2010202162; European (UK) Patent No. EP1754965; Hong Kong Patent Nos. HK1148587 and HK1148586; and foreign counterparts thereof.
xMAP INTELLIFLEX®
This product, or use thereof, is covered in whole or in part by US Patent Nos. D914,905, 7,318,336, and 7,523,637; Australian Patent No. 2010202161; European (UK) Patent No. EP1754965; Hong Kong Patent No. HK1148587; and foreign counterparts thereof.
ARIES® System and ARIES® M1 System
This product, or use thereof, is covered in whole or in part by US Patent Nos. 7,754,148, 7,910,062, 8,029,746, 8,168,443, 8,476,078, 8,900,877, 9,074,250, 9,273,344, 9,539,577, 10,040,071, 10,047,391, 10,179,899, 10,317,420, and 10,851,336; Australian Patent Nos. 2012216238, 2014224115, 2015221472 and 2017201579; Hong Kong Patent Nos. HK1234001 and HK1234001; and foreign counterparts thereof.
xPONENT® versions 3.0 and 3.1
This product, or use thereof, is covered in whole or in part by US Patent Nos. 7,318,336 and 7,523,637; and Australian Patent No. 2010202161; and foreign counterparts thereof.
xPONENT® versions 4.2 and 4.3
This product, or use thereof, is covered in whole or in part by US Patent Nos. 8,532,351, 8,542,897, 8,859,996, 9,063,088, 9,286,504, 9,292,938, and 9,767,344; Hong Kong Patent Nos. HK1173828 and HK1200209 and foreign counterparts thereof.
VERIGENE® Processor SP
This product, or use thereof, is covered in whole or in part by US Patent No. 7,888,107.
VERIGENE® Reader
This product, or use thereof, is covered in whole or in part by US Patent No.7,110,585.
Guava® Muse® Cell Analyzer
This product, or use thereof, is covered in whole or in part by US Patent Nos. 7,320,775 and 8,922,778; and foreign counterparts thereof.
Guava® easyCyte™ and Guava® easyCyte™ HT Flow Cytometers
This product, or use thereof, is covered in whole or in part by US Patent Nos. 7,320,775, 7,847,923, and 8,184,271; and foreign counterparts thereof.
Amnis® CellStream® Flow Cytometer
This product, or use thereof, is covered in whole or in part by US Patent Nos. 6,618,140, 6,763,149, 7,006,710, 7,079,708, 7,286,719, and 8,131,053; and foreign counterparts thereof.
Amnis® FlowSight® Imaging Flow Cytometer
This product, or use thereof, is covered in whole or in part by US Patent Nos. 6,618,140, 6,763,149, 7,006,710, 7,079,708, 7,190,832, 7,286,719, 8,131,053, 8,150,136, and 9,528,989; and foreign counterparts thereof.
Amnis® ImageStream®X Mk II Imaging Flow Cyometer
This product, or use thereof, is covered in whole or in part by US Patent Nos. 6,618,140, 6,763,149, 7,006,710, 7,079,708, 7,190,832, 7,286,719, 8,005,314, 8,131,053, 8,150,136, 8,817,115, and 9,528,989; and foreign counterparts thereof.
Guava® InCyte™ Software
This product, or use thereof, is covered in whole or in part by US Patent Nos. 8,959,448 and 10,140,419; Australian Patent Nos. 2014200203 and 2018229448.
Reagents
MagPlex® Microspheres
This product is covered, in whole or in part, or made by processes covered by one or more of the following patents: US 7,718,262, 8,283,037, 8,568,881, 8,968,874, and 9,376,613; European (UK) Patent Nos. EP 1842211 and 2244270; Hong Kong Patent No. 1116913; and foreign counterparts thereof.
Magplex®-Avidin Microspheres
This product is covered, in whole or in part, or made by processes covered by one or more of the following patents: US 7,718,262, 8,283,037, 8,568,881, 8,968,874, and 9,376,613; European (UK) Patent Nos. EP 1842211 and 2244270; Hong Kong Patent No. 1116913; and foreign counterparts thereof.
xTAG® Microspheres
This product, or the use or manufacture thereof, is covered, in whole or in part, by one or more of the following patents: US 7,645,868, and US 8,624,014; and foreign counterparts thereof.
MagPlex-TAG™ Microspheres
This product, or the use or manufacture thereof, is covered, in whole or in part, by one or more of the following patents: US 7,718,262, US 7,645,868, US 8,624,014, 8,283,037, 8,568,881, 8,968,874, and 9,376,613; European (UK) Patent Nos. EP 1842211 and EP 2244270; Hong Kong Patent No. 1116913; and foreign counterparts thereof.
MAGPIX® Calibration Kit
This product is covered, in whole or in part, or made by processes covered by one or more of the following patents: US 7,718,262, 8,283,037, 8,568,881, 8,968,874, and 9,376,613; European (UK) Patent Nos. EP 1842211 and 2244270; Hong Kong Patent No. 1116913; and foreign counterparts thereof.
MAGPIX® Performance Verification Kit
This product is covered, in whole or in part, or made by processes covered by one or more of the following patents: US 7,718,262, 8,283,037, 8,568,881, 8,968,874, and 9,376,613; European (UK) Patent Nos. EP 1842211 and 2244270; Hong Kong Patent No. 1116913; and foreign counterparts thereof.
MultiCode® ISOlution
This product, or use thereof, is covered in whole or in part by one or more of US Patent Nos: 7,820,808 and 8,313,932; and Australian Patent No. 2004227353; and foreign counterparts thereof.
ARIES® Extraction Cassette
This product, or use thereof, is covered in whole or in part by one or more of US Patent Nos: 7,422,850, 7,727,473, 8,124,024, 8,168,443, 8,372,340, 8,476,078, 8,900,877, 9,017,617, 9,074,250, and 10,646,875; Australian Patent Nos. 2006304623, 2011220873, 2012216238, and 2014224115; European (UK) Patent No. EP1945753; and foreign counterparts thereof.
ARIES® MultiCode® Ready Mix
This product, or use thereof, is covered in whole or in part by US Patent No. 10,144,954.
ARIES® MultiCode® DNA Ready Mix
This product, or use thereof, is covered in whole or in part by US Patent No. 10,144,954.
Assays
xTAG® Gastrointestinal Pathogen Panel (xTAG GPP)
This product is covered, in whole or in part, or made by processes covered by one or more of the following patents: US 7,718,262, US 7,645,868, US 8,624,014, US 8,283,037, US 8,568,881, US 8,968,874, and US 9,376,613; European (UK) Patent Nos. EP 1842211 and EP 2244270; Hong Kong Patent No. 1116913; and foreign counterparts thereof.
xTAG® Cystic Fibrosis Assays (xTAG® Cystic Fibrosis 39 kit v2, xTAG® Cystic Fibrosis 60 kit v2, xTAG® Cystic Fibrosis 71 kit v2)
This product is covered, in whole or in part, or made by processes covered by one or more of the following patents: US 7,645,868 and US 8,624,014; and foreign counterparts thereof.
Luminex Molecular Diagnostics, Inc. has licensed the rights to sell products for the analysis of genetic variants in the CFTR genes from the Hospital for Sick Children (Toronto) and the University of Michigan. The purchaser of this kit is granted the right to use the contents of this kit to perform analyses of these genetic variants, and to sell the results of this analysis if desired. No rights or licenses are granted to the purchaser of this kit to perform these analyses other than through the direct use of the contents of this kit.
xTAG® CYP2C19 Kit v3 (xTAG® P450-2C19 Kit v3)
This product is covered, in whole or in part, or made by processes covered by one or more of the following patents: US 7,718,262, US 7,645,868, US 8,624,014, US 8,283,037, US 8,568,881, US 8,968,874, and US 9,376,613; Australian Patent Nos. 2002227829 and 2008201349; European (UK) Patent Nos. EP 1842211, EP 2244270, and EP 1364065; Hong Kong Patent No. 1116913; and foreign counterparts thereof.
MultiCode®-RTx HSV 1&2 Kit
This product, or use thereof, is covered in whole or in part by one or more of US Patent No. 7,517,651; European (UK) Patent No. EP1349954; Hong Kong Patent No. 1061410; and foreign counterparts thereof.
xMAP® Biothreat Toxin Panel
This product is covered, in whole or in part, or made by processes covered by one or more of the following patents: US 7,718,262, US 8,283,037, US 8,568,881, US 8,968,874, and US 9,376,613; Australian Patent No. 2011280967; European (UK) Patent Nos. EP 1842211 and 2244270; Hong Kong Patent No. 1116913; and foreign counterparts thereof.
xMAP® Molecular Shiga Toxin-producing Escherichia coli (STEC) Serotyping Assay
This product is covered, in whole or in part, or made by processes covered by one or more of the following patents: US 7,718,262, US 8,283,037, US 8,568,881, US 8,968,874, and US 9,376,613; Australian Patent No. 2011280967; European (UK) Patent Nos. EP 1842211 and 2244270; Hong Kong Patent No. 1116913; and foreign counterparts thereof.
xMAP® MultiFLEX® BioAssays
This product is covered, in whole or in part, or made by processes covered by one or more of the following patents: US 7,718,262, US 8,283,037, US 8,568,881, US 8,968,874, and US 9,376,613; European (UK) Patent Nos. EP 1842211 and 2244270; Hong Kong Patent No. 1116913; and foreign counterparts thereof.
xMAP® MultiFLEX® Zika RNA Assay
This product is covered, in whole or in part, or made by processes covered by one or more of the following patents: US 7,718,262, US 8,283,037, US 8,568,881, US 8,968,874, and US 9,376,613; European (UK) Patent Nos. EP 1842211 and 2244270; Hong Kong Patent No. 1116913; and foreign counterparts thereof.
xMAP® SARS-CoV-2 Multi-Antigen IgG Assay
This product is covered, in whole or in part, or made by processes covered by one or more of the following patents: US 7,718,262, US 8,283,037, US 8,568,881, US 8,968,874, and US 9,376,613; Australian Patent No. 2011280967; European (UK) Patent Nos. EP 1842211 and 2244270; Hong Kong Patent No. 1116913; and foreign counterparts thereof.
ARIES® GBS Assay
This product, or use thereof, is covered in whole or in part by one or more of US Patent Nos: 7,422,850, 7,727,473, 8,124,024, 8,168,443, 8,476,078, 8,900,877, 9,017,617, 9,074,250, and 10,646,875; Australian Patent Nos. 2006304623, 2011220873, 2012216238, and 2014224115; European (UK) Patent No. EP1945753; and foreign counterparts thereof.
ARIES® Group A Strep Assay
This product, or use thereof, is covered in whole or in part by one or more of US Patent Nos: 7,422,850, 7,727,473, 8,124,024, 8,168,443, 8,476,078, 8,900,877, 9,017,617, 9,074,250, and 10,646,875; Australian Patent Nos. 2006304623, 2011220873, 2012216238, and 2014224115; European (UK) Patent No. EP1945753; and foreign counterparts thereof.
ARIES® Flu A/B & RSV Assay
This product, or use thereof, is covered in whole or in part by one or more of US Patent Nos: 7,422,850, 7,727,473, 8,124,024, 8,168,443, 8,476,078, 8,900,877, 9,017,617, 9,074,250, and 10,646,875; Australian Patent Nos. 2006304623, 2011220873, 2012216238, and 2014224115; European (UK) Patent No. EP1945753; and foreign counterparts thereof.
ARIES® HSV 1&2 Assay
This product, or use thereof, is covered in whole or in part by one or more of US Patent Nos: 7,422,850, 7,727,473, 8,124,024, 8,168,443, 8,476,078, 8,900,877, 9,017,617, 9,074,250, and 10,646,875; Australian Patent Nos. 2006304623, 2011220873, 2012216238, and 2014224115; European (UK) Patent No. EP1945753; and foreign counterparts thereof.
ARIES® Bordetella Assay
This product, or use thereof, is covered in whole or in part by one or more of US Patent Nos: 7,422,850, 7,727,473, 8,124,024, 8,168,443, 8,476,078, 8,900,877, 9,017,617, 9,074,250, and 10,646,875; Australian Patent Nos. 2006304623, 2011220873, 2012216238, and 2014224115; European (UK) Patent No. EP1945753; and foreign counterparts thereof.
ARIES® C. difficile Assay
This product, or use thereof, is covered in whole or in part by one or more of US Patent Nos: 7,422,850, 7,727,473, 8,124,024, 8,168,443, 8,476,078, 8,900,877, 9,017,617, 9,074,250, and 10,646,875; Australian Patent Nos. 2006304623, 2011220873, 2012216238, and 2014224115; European (UK) Patent No. EP1945753; and foreign counterparts thereof.
ARIES® Norovirus Assay
This product, or use thereof, is covered in whole or in part by one or more of US Patent Nos: 7,422,850, 7,727,473, 8,124,024, 8,168,443, 8,476,078, 8,900,877, 9,017,617, 9,074,250, and 10,646,875; Australian Patent Nos. 2006304623, 2011220873, 2012216238, and 2014224115; European (UK) Patent No. EP1945753; and foreign counterparts thereof.
ARIES® MRSA Assay
This product, or use thereof, is covered in whole or in part by one or more of US Patent Nos: 7,422,850, 7,727,473, 8,124,024, 8,168,443, 8,476,078, 8,900,877, 9,017,617, 9,074,250, and 10,646,875; Australian Patent Nos. 2006304623, 2011220873, 2012216238, and 2014224115; European (UK) Patent No. EP1945753; and foreign counterparts thereof.
ARIES® SARS-CoV-2 Assay
This product, or use thereof, is covered in whole or in part by one or more of US Patent Nos: 7,422,850, 7,727,473, 8,124,024, 8,168,443, 8,476,078, 8,900,877, 9,017,617, 9,074,250, and 10,646,875; Australian Patent Nos. 2006304623, 2011220873, 2012216238, and 2014224115; European (UK) Patent No. EP1945753; and foreign counterparts thereof.
NxTAG® Respiratory Pathogen Panel
This product is covered, in whole or in part, or made by processes covered by one or more of the following patents: US 7,718,262, US 7,645,868, US 8,624,014, US 8,283,037, US 8,568,881, US 8,968,874, and US 9,376,613; European (UK) Patent Nos. EP 1842211 and EP 2244270; Hong Kong Patent No. 1116913; and foreign counterparts thereof.
NxTAG® CoV Extended Panel
This product is covered, in whole or in part, or made by processes covered by one or more of the following patents: US 7,718,262, US 7,645,868, US 8,624,014, US 8,283,037, US 8,568,881, US 8,968,874, and US 9,376,613; European (UK) Patent Nos. EP 1842211 and EP 2244270; Hong Kong Patent No. 1116913; and foreign counterparts thereof.
NxTAG® Respiratory Pathogen Panel (RPP) + SARS-CoV-2
This product is covered, in whole or in part, or made by processes covered by one or more of the following patents: US 7,718,262, US 7,645,868, US 8,624,014, US 8,283,037, US 8,568,881, US 8,968,874, and US 9,376,613; European (UK) Patent Nos. EP 1842211 and EP 2244270; Hong Kong Patent No. 1116913; and foreign counterparts thereof.
NxTAG® Gastrointestinal Pathogen Panel (GPP)
This product is covered, in whole or in part, or made by processes covered by one or more of the following patents: US 7,718,262, US 7,645,868, US 8,624,014, US 8,283,037, US 8,568,881, US 8,968,874, and US 9,376,613; European (UK) Patent Nos. EP 1842211 and EP 2244270; Hong Kong Patent No. 1116913; and foreign counterparts thereof.
VERIGENE® Gram-Positive Blood Culture (BC-GP) Test
This product, or use thereof, is covered in whole or in part by US Patent No. 7,695,952.
VERIGENE® Gram-Negative Blood Culture (BC-GN) Test
This product, or use thereof, is covered in whole or in part by US Patent No. 7,695,952.
VERIGENE® Respiratory Pathogens Flex (RP Flex) Test
This product, or use thereof, is covered in whole or in part by US Patent No. 7,695,952.
VERIGENE® Enteric Pathogens Test
This product, or use thereof, is covered in whole or in part by US Patent No. 7,695,952.
VERIGENE® C. difficile Test
This product, or use thereof, is covered in whole or in part by US Patent No. 7,695,952.
Accessories
Magnetic Plate Separator
This product, or use thereof, is covered in whole or in part by US Patent No. 8,747,677.